Abstract

In the ever-changing landscape of device therapy for pulmonary embolism, it is important to understand the rationale behind the ongoing explosion in the development of new device therapies. There needs to be an in-depth understanding of risk stratification in pulmonary embolism and indications for therapy. Selecting the ideal device for a particular pulmonary embolism subset remains elusive and poorly defined. Knowledge of the risks, benefits, capabilities, and potential limitations of each device is crucial.

Keywords: Pulmonary embolism, catheter-directed thrombolysis, mechanical thrombectomy, thrombolysis, ultrasound-assisted thrombolysis, PERT.